<DOC>
	<DOCNO>NCT00869388</DOCNO>
	<brief_summary>This study evaluate toxicity associate escalating dos rBBX-01 give bi-weekly patient solid tumor .</brief_summary>
	<brief_title>A Phase I Study Bi-Weekly rBBX-01 Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Confirmed metastatic unresectable , resistant solid tumor . Gynecologic tumor prefer . 18 year GOG performance status great equal 2 Life expectancy great 6 month Acceptable organ marrow function Willingness agree use adequate contraception prior study entry duration study participation Chemotherapy radiotherapy within 4 week ( 6 week nitrosoureas mitomycin C ) prior enter study recover adverse event due agent administer 4 week earlier Not receive investigational agent Known brain metastasis Uncontrolled intercurrent illness include , limited ongoing ore active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrythmia , psychiatric illness/social situation would limit compliance study requirement Pregnancy Immunosuppression include subject know HIV infection immunosuppressive drug autoimmune disorder Penicillin allergy Symptomatic prostate hypertrophy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>malignant</keyword>
	<keyword>resistant</keyword>
	<keyword>solid tumor</keyword>
</DOC>